267 related articles for article (PubMed ID: 17882957)
1. [Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives].
Fu XZ; Tang L; Yuan M; Shi JS
Yao Xue Xue Bao; 2007 Jul; 42(7):735-40. PubMed ID: 17882957
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.
Handzlik J; Maciag D; Kubacka M; Mogilski S; Filipek B; Stadnicka K; Kieć-Kononowicz K
Bioorg Med Chem; 2008 Jun; 16(11):5982-98. PubMed ID: 18490167
[TBL] [Abstract][Full Text] [Related]
4. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists.
Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK
J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.
Leonardi A; Motta G; Boi C; Testa R; Poggesi E; De Benedetti PG; Menziani MC
J Med Chem; 1999 Feb; 42(3):427-37. PubMed ID: 9986714
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors.
Marona H; Szkaradek N; Kubacka M; Bednarski M; Filipek B; Cegla M; Szneler E
Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Acta Pol Pharm; 2009; 66(6):649-62. PubMed ID: 20050529
[TBL] [Abstract][Full Text] [Related]
8. Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives.
Takahashi T; Sakuraba A; Hirohashi T; Shibata T; Hirose M; Haga Y; Nonoshita K; Kanno T; Ito J; Iwaasa H; Kanatani A; Fukami T; Sato N
Bioorg Med Chem; 2006 Nov; 14(22):7501-11. PubMed ID: 16919461
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonists.
Abou-Seri SM; Abouzid K; Abou El Ella DA
Eur J Med Chem; 2011 Feb; 46(2):647-58. PubMed ID: 21193252
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore-based design, synthesis, biological evaluation, and 3D-QSAR studies of aryl-piperazines as alpha(1)-adrenoceptor antagonists.
Li MY; Fang H; Xia L
Bioorg Med Chem Lett; 2005 Jul; 15(13):3216-9. PubMed ID: 15935663
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR-study for novel arylpiperazine derivatives of 5-arylidenehydantoin with α₁-adrenoceptor antagonistic properties.
Handzlik J; Szymańska E; Wójcik R; Dela A; Jastrzębska-Więsek M; Karolak-Wojciechowska J; Fruziński A; Siwek A; Filipek B; Kieć-Kononowicz K
Bioorg Med Chem; 2012 Jul; 20(14):4245-57. PubMed ID: 22739084
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and serotonergic activity of variously substituted (3-amido)phenylpiperazine derivatives and benzothiophene-4-piperazine derivatives: novel antagonists for the vascular 5-HT1B receptor.
Moloney GP; Garavelas A; Martin GR; Maxwell M; Glen RC
Eur J Med Chem; 2004 Apr; 39(4):305-21. PubMed ID: 15072840
[TBL] [Abstract][Full Text] [Related]
14. [Metabolites of R, S-1-(2-methoxyphenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazin in rat plasma].
Li L; Zhou X; Yuan M; Zhou H; Wang DP
Yao Xue Xue Bao; 2006 Jan; 41(1):80-4. PubMed ID: 16683533
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
[TBL] [Abstract][Full Text] [Related]
16. Preparation of piperazine derivatives as 5-HT7 receptor antagonists.
Yoon J; Yoo EA; Kim JY; Pae AN; Rhim H; Park WK; Kong JY; Park Choo HY
Bioorg Med Chem; 2008 May; 16(10):5405-12. PubMed ID: 18456500
[TBL] [Abstract][Full Text] [Related]
17. Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.
Di Fabio R; Griffante C; Alvaro G; Pentassuglia G; Pizzi DA; Donati D; Rossi T; Guercio G; Mattioli M; Cimarosti Z; Marchioro C; Provera S; Zonzini L; Montanari D; Melotto S; Gerrard PA; Trist DG; Ratti E; Corsi M
J Med Chem; 2009 May; 52(10):3238-47. PubMed ID: 19388677
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives.
Dylag T; Zygmunt M; Maciag D; Handzlik J; Bednarski M; Filipek B; Kieć-Kononowicz K
Eur J Med Chem; 2004 Dec; 39(12):1013-27. PubMed ID: 15571863
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of carbamic acid 1-phenyl-3-(4-phenyl-piperazine-1-yl)-propyl ester derivatives as new analgesic agents.
Chae E; Yi H; Choi Y; Cho H; Lee K; Moon H
Bioorg Med Chem Lett; 2012 Apr; 22(7):2434-9. PubMed ID: 22386241
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-activity relationship study of novel alpha1a-selective adrenoceptor antagonists.
Singh P; Kumar R
J Enzyme Inhib; 2001 Oct; 16(4):331-8. PubMed ID: 11916138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
